ACKNOWLEDGEMENTS

This guide would not have been possible without the generosity of the people whose professional experiences are reflected in this text.

Steven Aaronoff, Attorney, McDermitt, Will, and Emory

Beth E. Arnold, Attorney, Foley, Hoag & Eliott LLP

Michael K. Barron, Attorney, Nixon Peabody LLP

Frank Bilstein, Managing Director, Simon-Kucher

Janice T. Bourque, President, Mass Biotech Council Anthony R. Briggs, PhD Candidate, MIT Sloan

Joyce Brinton, Director of Tech Licensing, Harvard

David E. Brook, Attorney, Hamilton, Brook

Mark Chalek, Director of Corporate Research, BIDMC

Paul T. Clark, Attorney, Clark and Elbing LLP

Ron Cohen MD, President and CEO, Acorda Therapeutics

Dave G. Conlin, Attorney, Edwards and Angell LLP

Dana B. Edelman, Collaborative Seed & Growth Partners

Barry Eisenstein MD, Executive Vice President, Cubist

Ron I. Eisenstein, Attorney, Nixon Peabody LLP

Martin E. Fishkin, Attorney, Prince, Lobel, Glovsky

Gregory J. Glover MD, Attorney, Ropes and Gray

Marc E. Goldberg, BioVentures Investors

Robert Gottlieb, Managing Director, Feinstein Kean

Peter Hecht PhD, CEO, Microbia

Mark A. Hofer, Attorney, Brown, Rudnick, Freed, & Gesmer

Julie Huang, Vice President, Financial Dynamics

Jonathan H. Hulbert, Attorney, Foley, Hoag & Eliott LLP

Skip Irving, Managing Director, Health Advances

Paul Kidwell, Communications/PR Consultant

Michael King, Managing Director, Banc of America Securities

William A. Knowlton, Attorney, Ropes and Gray

Roberto G. Kolter, Professor, Harvard Medical School

Liisa T. Kuhn PhD, Instructor, The Children's Hospital

Jeffrey Labovitz PhD, Director of Tech Transfer, UCLA

Evan M. Lebson, VP-Treasurer, Genzyme Corporation

Gregory P. Lucas, Senior Managing Director, Insignia ESG

Michael E. Lytton, General Partner, Oxford Bioscience

Gary P. Magnant, President, Thermoceramix

Jack Malley, Partner, FirstJensenGroup

Louis Myers PhD, Attorney, Fish and Richardson

Lita L. Nelsen, Director of Technology Licensing, MIT

Michael R. Pavia PhD, Partner, Oxford Biosciences

E. Robin Plumer PhD, Attorney, Wolf, Greenfield & Sacks

Randy J. Pritzker, Attorney, Wolf, Greenfield & Sacks

William S. Reardon, Partner, PricewaterhouseCoopers

Robert H. Rubin MD, Professor, Harvard Medical School

Bruce Rubinger PhD, Managing Director, Global Prior Art

S. Una Ryan MD, CEO, Avant Immunotherapeutics Alfred Server PhD, Attorney, Hale and Dorr LLP

David Sherris PhD, Sherris Pharma Partners

Steven D. Singer, Attorney, Hale and Dorr LLP

Albert L. Sokol, Attorney, Edwards and Angell LLP

Ashley J. Stevens PhD, Director of Technology Transfer, BU

Matthew P. Vincent PhD, Attorney, Ropes and Gray

Christopher T. Walsh PhD, Professor, Harvard Med. School

Jeffrey M. Wiesen, Attorney, Mintz, Levin

Steven A. Wilcox, Attorney, Ropes and Gray

Walter Winshall PhD, Collaborative Seed & Growth Partners

Larry S. Wittenberg, Testa, Hurwitz & Thibeault LLP

I am very grateful to the guest authors for generously contributing their expertise to the Guide:

Peter B. Finn ESQ, Senior Partner, Rubin and Rudman Nathaniel

S. Howe Jr., Vice President, Marsh USA Inc

Kenneth B. Klein M.D., Endpoint,

Michael D. Miller MD

Betsy M. Ohlsson-Wilhelm Ph.D. and Katharine A.

Muirhead Ph.D., SciGro, Jack Malley, Partner, FirstJensenGroup, Christopher Pimental, Vice President, Lexten Inc.

Alfred Vaz, Vice President, Vertex

I also thank Cayce Denton, Jennifer D'Onofrio, and Daniel Zahler for providing valuable editorial support.

A special thank you goes to Richard H. Aldrich, my mentor, who, in the time that I have worked for him at RA Capital, has taught me much of what I know about investing and business. I appreciate the time he devoted to discussing and editing the text.

My family and friends, especially Laurie, could not have been more supportive. Thank you.